Project Grant R21NS135360
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$440K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This $1,550,682 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to understand the mechanisms controlling central nervous system (CNS) myelin sheath length and their implications for neurological disorders. The primary objective is to determine how axon diameter serves as an instructive cue that triggers oligodendrocyte...
This $458,189 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate how membrane-remodeling factors regulate oligodendrocyte morphology and myelination in the central nervous system. The primary objectives of this 5-year research project are to: (1) identify membrane-remodeling factors expressed in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $444,599 to investigate the impact of neuronal activity on oligodendrocyte progenitor cell differentiation and myelination. The research aims to characterize transcriptome changes in oligodendrocyte progenitor cells when cortical neuronal activity is manipulated using designer...
This $232,524 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the role of the AMPK signaling pathway in regulating oligodendrocyte development and myelination during postnatal brain development. The principal investigator at Stony Brook University will conduct studies in mice to assess how AMPK...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $2,503,949.00 in funding to Rockefeller University for a research project titled "Applying RNA Logic in Space and Time to Neurologic Disease". The project aims to develop new techniques and concepts for discovering therapeutic targets for neurological diseases...
This $426,650 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to develop a hybrid differentiation strategy for efficiently deriving region-specific cell populations, such as oligodendrocytes and neural crest progenitors, from human pluripotent stem cells. The project builds upon the awardee's (Trustees of Tufts College)...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports research to characterize the role of the transcription factor BMAL1 in oligodendrocyte precursor cell (OPC) differentiation and myelination. The $251,370 award to The Leland Stanford Junior University, effective August 1, 2024 through June 30, 2026, will enable the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $614,009 to support research focused on understanding the molecular mechanisms involved in oligodendrocyte myelination and remyelination. The goal is to identify critical factors that promote myelin production and overcome inhibitory signals, with the aim of improving myelin repair...
This Project Grant award, valued at $352,073.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award supports research focused on developing a therapeutic to address demyelinating neuropathies, a class of neurological disorders characterized by impaired myelin formation. Specifically, the research will investigate the use of an...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,500,600 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Rector & Visitors of the University of Virginia (University of Virginia) to investigate the role of specific genes, including TMEM125B and JAMS 2 & 3, in central nervous system (CNS) myelination. The research aims to: 1) determine the role of TMEM125B in CNS myelination, 2)...